Different Dosages of Corticosteroid and Routes of Administration in Mandibular Third Molar Surgery: a Systematic Review

Abstract

ObjectivesThe objective of the present systematic review was to test the hypothesis of no difference in facial swelling, pain and trismus after surgical removal of mandibular third molar with different dosages of corticosteroids and administration routes.Material and MethodsA MEDLINE (PubMed), Embase database and Cochrane Library search in combination with a hand-search of relevant journals was conducted by including randomized controlled trials published in English until 1st December 2017.ResultsSeven studies fulfilled the inclusion criteria. Considerable variation in the included studies prevented meta-analysis from being performed. Preoperative submucosal injection of corticosteroids significantly diminishes facial swelling, pain and trismus compared with placebo. However, different dosages of corticosteroid and administration routes reveal contrary results indicating that administration of a higher dosage of corticosteroids do not necessarily cause a further decrease in facial swelling, pain and trismus.ConclusionsConsequently, the optimal dosage of corticosteroids and administration route for diminishing postsurgical morbidity and improve quality of life after surgical removal of mandibular third molar is presently unknown. Therefore, further well-designed randomized clinical trials including a standardised protocol, patient-reported outcome measures and three-dimensional analysis of facial swelling is needed.

Therapeutic efficacy of cryotherapy on facial swelling, pain, trismus and quality of life after surgical removal of mandibular third molars: A systematic review

“…Facial swelling, pain and trismus are well‐known sequelae caused by the physiological inflammatory response to the surgical trauma . Various pharmacological and therapeutic methods including non‐steroidal anti‐inflammatory drugs, corticosteroids, surgical drains, local compression and low‐level laser therapy are often used to suppress the inflammatory response after SRM3, and the outcome has been documented in systematic reviews and meta‐analyses …”

What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review

“…In the field of oral surgery they are the preferred pharmaceutical agents for decreasing the severity of the natural inflammatory response after surgical extractions of wisdom teeth to reduce postoperative edema and swelling. 95 Several oral diseases that affect the oral mucosa, and that have an immune-based etiology are managed by corticosteroids. On the other hand, many dental patients are on corticosteroids either as a replacement therapy or as treatment for autoimmune diseases.…”

Uso de corticoides por cirurgiões bucomaxilofaciais do Brasil

“…A utilização de corticoides de forma inadequada pode comprometer a saúde do paciente, tendo em vista os efeitos adversos aos quais podem levar, como supressão da glândula 1 suprarrenal, aumento do índice de infecção, catarata, glaucoma, hipertensão, miopatia, osteoporose, alterações no humor ou personalidade e psicose [3][4][5] . Os corticoides administrados por via oral ou endovenosa são mais propensos a causar esses efeitos adversos do que os de uso tópico ou inalatório 1 .…”

“…Os reais benefícios da utilização de corticoides em procedimentos cirúrgicos realizados pelos cirurgiões bucomaxilofaciais deixam espaço para dúvidas quanto às dosagens, ao momento de utilização, à via de administração, e, até mesmo, a própria efetividade da droga. Desse modo, talvez, a utilização desse popular medicamento possa não estar sendo a mais adequada [2][3][4][5][6] .…”